Golden Biotechnology Corporation Stock price
Equities
4132
TW0004132006
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.6 TWD | +1.61% | -4.10% | -19.49% |
Sales 2021 | 81.77M 2.56M | Sales 2022 | 218M 6.81M | Capitalization | 8.55B 267M |
---|---|---|---|---|---|
Net income 2021 | -444M -13.88M | Net income 2022 | -272M -8.5M | EV / Sales 2021 | 204 x |
Net cash position 2021 | 438M 13.71M | Net cash position 2022 | 239M 7.47M | EV / Sales 2022 | 38.1 x |
P/E ratio 2021 |
-38.7
x | P/E ratio 2022 |
-31.4
x | Employees | 122 |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 100% |
1 day | +1.61% | ||
1 week | -4.10% | ||
Current month | -21.20% | ||
1 month | -18.35% | ||
3 months | -18.77% | ||
6 months | -25.38% | ||
Current year | -19.49% |
Managers | Title | Age | Since |
---|---|---|---|
Ching Tien Su
CEO | Chief Executive Officer | - | 19-03-03 |
Li Yue Wu
FOU | Founder | - | 02-09-26 |
Mu Tseng Tseng
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sheng Yung Liu
FOU | Founder | - | 02-09-26 |
Li Yue Wu
FOU | Founder | - | 02-09-26 |
Yue Chun Chen
BRD | Director/Board Member | - | 09-06-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 115 M€ | +4.95% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-27 | 31.6 | +1.61% | 477 370 |
24-03-27 | 31.1 | -2.51% | 565,763 |
24-03-26 | 31.9 | -3.48% | 465,023 |
24-03-25 | 33.05 | +2.01% | 286,100 |
24-03-22 | 32.4 | +0.62% | 421,511 |
End-of-day quote Taipei Exchange, March 27, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-19.49% | 138M | |
+3.11% | 108B | |
+9.84% | 104B | |
+6.58% | 23.66B | |
-12.27% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-12.89% | 16.19B | |
+4.90% | 13.72B | |
+35.10% | 12.22B |